HB
HCW Biologics Inc.
SEC filingBiotechnology · Miramar, FL
Amount raised$1.6Msold at filing
Total offering$1.6M
Investors in the raise4count reported to the SEC
FiledAug 6, 2026first sale Jul 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rebecca C. ByamExecutive Officer
Scott T. GarrettDirector
Rick S. GreeneDirector
Lisa M. GilesDirector
Lee M. FlowersExecutive Officer
Peter C. RhodeExecutive Officer
Hing C. WongExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.